{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:35:16Z","timestamp":1773322516413,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/bega.2001.0185","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"371-384","source":"Crossref","is-referenced-by-count":8,"title":["Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease"],"prefix":"10.1053","volume":"15","author":[{"given":"Philip O.","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radu","family":"Tutuian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2001.0185_RF1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","article-title":"Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmstead county, Minnesota","volume":"112","author":"Locke","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF2","first-page":"29","article-title":"Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in general population: results from the Domestic\/International Gastroenterology Surveillance Study (DIGEST)","volume":"231","author":"Stanghellini","year":"1999","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0889-8553(05)70094-7","article-title":"Extraesophageal gastroesophageal reflux disease. Presentations and approach to treatment","volume":"28","author":"Fennerty","year":"1999","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1053\/bega.2001.0185_RF4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000200917","article-title":"Appropriate acid suppression for the management of gastro-oesophageal reflux disease","volume":"51","author":"Bell","year":"1992","journal-title":"Digestion"},{"key":"10.1053\/bega.2001.0185_RF5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2036.1990.tb00495.x","article-title":"Combined gastric and oesophageal pH-metry in patients with reflux disease, resistant to omeprazole","volume":"4","author":"Klinkenberg-Knol","year":"1990","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF6","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.1995.00430200044008","article-title":"Guidelines for the diagnosis and therapeutic approach to gastroesophageal reflux disease","volume":"155","author":"Castell","year":"1995","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.2001.0185_RF7","first-page":"1735","article-title":"Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study","volume":"86","author":"Cloud","year":"1991","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.1987.00370080123022","article-title":"Ranitidine therapy for gastroesophageal reflux disease: results of a large double-blind trial","volume":"147","author":"Sontag","year":"1987","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.2001.0185_RF9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0889-8553(05)70092-3","article-title":"Overview of medical therapy for gastroesophageal reflux disease","volume":"28","author":"DeVault","year":"1999","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1053\/bega.2001.0185_RF10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/00365521.1984.12005747","article-title":"Prolonged influence of a meal on the effect of ranitidine","volume":"19","author":"Frislid","year":"1984","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3109\/00365529609003113","article-title":"Gastro-esophageal reflux during three months of therapy with ranitidine in reflux esophagitis","volume":"31","author":"Hatlebakk","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0889-8553(05)70093-5","article-title":"Medical therapy: management of the refractory patient","volume":"28","author":"Hatlebakk","year":"1999","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1053\/bega.2001.0185_RF13","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0016-5085(94)90562-2","article-title":"H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: \u2018For whom the bell tolls\u2019","volume":"107","author":"Fennerty","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2036.1998.00381.x","article-title":"Pantoprazole 20mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis","volume":"12","author":"Dettmer","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1023\/A:1018822532736","article-title":"Rabeprazole in treatment of acid peptide diseases: results of three placebo-controlled dose\u2013response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GORD). The Rabeprazole Study Group","volume":"43","author":"Cloud","year":"1998","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0185_RF16","first-page":"1749","article-title":"Efficacy and safety of lansoprazole in the treatment of erosive esophagitis. The Lansoprazole Study Group","volume":"91","author":"Castell","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of severe peptic esophagitis after treatment with omeprazole","volume":"95","author":"Hetzel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF18","doi-asserted-by":"crossref","first-page":"A17","DOI":"10.1016\/S0016-5085(00)82137-X","article-title":"A PPI is a PPI is a PPI: lessons from prolonged intragastric pH monitoring","volume":"118","author":"Tutuian","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2036.1993.tb00125.x","article-title":"Does 40mg of omeprazole daily offer additional benefit over 20mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux esophagitis?","volume":"7","author":"Bate","year":"1993","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1365-2036.2000.00813.x","article-title":"Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of GORD","volume":"14","author":"Lind","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.2000.00856.x","article-title":"Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux esophagitis patients: a randomized controlled study","volume":"14","author":"Kharilas","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF22","doi-asserted-by":"crossref","first-page":"22438","DOI":"10.1074\/jbc.272.36.22438","article-title":"Sites of action of the gastric H, K-ATPase with extracytoplasmic thiol reagents","volume":"272","author":"Bensancon","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/bega.2001.0185_RF23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02090077","article-title":"Variability in individual response to various doses of omeprazole. Implication for antinuclear therapy","volume":"39","author":"Savarino","year":"1994","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0185_RF24","first-page":"1636","article-title":"Omeprazole 20mg b.i.d. vs. lansoprazole 30mg b.i.d. in control of intragastric acidity","volume":"93","author":"Hatlebakk","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1365-2036.2000.00813.x","article-title":"Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease","volume":"14","author":"Lind","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1046\/j.1365-2036.2000.00829.x","article-title":"Proton pump inhibitors: better acid suppression when taken before a meal than without a meal","volume":"14","author":"Hatlebakk","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF27","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/003655298750026714","article-title":"CYP2C19 genotype and phenotype determined with omeprazole in patients with acid-related disorders with and withoutHelicobacter pylori infection","volume":"33","author":"Sagar","year":"1998","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF28","doi-asserted-by":"crossref","first-page":"A1210","DOI":"10.1016\/S0016-5085(00)80670-8","article-title":"Pharmacokinetics and dose-response relationship of esomeprazole","volume":"118","author":"Anderssor","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF29","first-page":"1532","article-title":"Optimal dosing of omeprazole 40mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls","volume":"91","author":"Kuo","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1365-2036.1998.00426.x","article-title":"Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40mg daily","volume":"12","author":"Hatlebakk","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF31","first-page":"1641","article-title":"H. pylori infection increases nocturnal acid control on proton pump inhibitors","volume":"93","author":"Katz","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1046\/j.1365-2036.2000.00799.x","article-title":"Helicobacter pylori influences nocturnal acid breakthrough","volume":"14","author":"Katzube","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2036.1999.00531.x","article-title":"The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine","volume":"13","author":"van Herwaarden","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF34","first-page":"1527","article-title":"Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy","volume":"91","author":"Leite","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1572-0241.1998.221_a.x","article-title":"Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors","volume":"93","author":"Peghini","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1046\/j.1365-2036.1998.00419.x","article-title":"Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors","volume":"12","author":"Katz","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF37","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1046\/j.1365-2036.1999.00641.x","article-title":"Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors","volume":"13","author":"Fouad","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF38","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0016-5085(98)70010-1","article-title":"Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects","volume":"115","author":"Peghini","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1365-2036.1999.00499.x","article-title":"Bedtime ranitidine does not eliminate the need for a second dose of omeprazole to suppress nocturnal gastric pH","volume":"13","author":"Khoury","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF40","first-page":"1623","article-title":"Zantac 75=Prilosec 20mg to block nighttime acid!","volume":"93","author":"Robinson","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF41","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1572-0241.2000.02451.x","article-title":"Ranitidine 75mg improves control of overnight intragastric pH during omeprazole therapy","volume":"95","author":"Tutuian","year":"2000","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF42","first-page":"2419","article-title":"Nocturnal acid breakthrough and H2RA's\u2014another viewpoint","volume":"95","author":"Fackler","year":"2000","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF43","first-page":"A23","article-title":"Bedtime H2 blockers control nocturnal gastric acid breakthrough in GORD patients","volume":"118","author":"Xue","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF44","first-page":"672","article-title":"Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus","volume":"90","author":"Katzka","year":"1995","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1572-0241.1998.211_a.x","article-title":"Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus","volume":"93","author":"Ouatu-Lascar","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1365-2036.2000.00749.x","article-title":"Failure of acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor","volume":"14","author":"Fass","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0185_RF47","first-page":"1844","article-title":"Dynamic effects of acid on Barrett's esophagus","volume":"89","author":"Fitzgerald","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF48","first-page":"1844","article-title":"Effect of up to 3 years high-dose lansoprazole on Barrett's esophagus","volume":"89","author":"Sampliner","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0185_RF49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/gut.47.1.154a","article-title":"Endoscopic regression of Barrett's esophagus during omeprazole treatment; a randomized double blind study","volume":"47","author":"Peters","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0185_RF50","first-page":"2600","article-title":"Effect of maximal acid reflux control on Barrett's esophagus (BE)","volume":"94","author":"Srinivasan","year":"1999","journal-title":"American Journal of Gastroenterology"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691801901854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691801901854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T21:10:13Z","timestamp":1581023413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691801901854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521691801901854"],"URL":"https:\/\/doi.org\/10.1053\/bega.2001.0185","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}